Alembic Pharma Q1 FY26: Decoding Growth, Margins & Future Earnings Potential

Alembic Pharma kicked off FY26 with mixed yet encouraging Q1 results. This analysis delves into the …

Aug 17, 2025 13:48

Alembic Pharma Shares Surge Over 10% on USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection

Alembic Pharmaceuticals Limited (APLLTD) announced on June 29, 2025, that it has received final …

Jun 30, 2025 12:30